Use of Plerixafor to Mobilize a Healthy Donor Infected with Influenza A

The combined use of plerixafor and granulocyte-colony stimulating factor (G-CSF) improves mobilization in poor mobilizers. However, there are limited data available on the use of plerixafor in healthy donors [1,2]. The effects of influenza A infection on stem cell mobilization are not known.

Saved in:
Bibliographic Details
Published in:Turkish journal of haematology 2018-05, Vol.35 (2), p.138-139
Main Authors: Yeral, Mahmut, Aytan, Pelin, Boğa, Can
Format: Article
Language:English
Subjects:
Antiviral Agents - therapeutic use
Bone marrow
Cytokines
Granulocyte Colony-Stimulating Factor - therapeutic use
healthy donor
Hematopoietic Stem Cell Mobilization - methods
Hematopoietic Stem Cell Transplantation - methods
Heterocyclic Compounds - therapeutic use
Humans
Infections
Influenza
influenza a
Influenza A virus - drug effects
Influenza A virus - isolation & purification
Influenza, Human - blood
Influenza, Human - drug therapy
Letters to the Editor
Male
Middle Aged
plerixafor
Stem cells
Tıp
Tissue Donors
Transplants & implants
Viral infections
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The combined use of plerixafor and granulocyte-colony stimulating factor (G-CSF) improves mobilization in poor mobilizers. However, there are limited data available on the use of plerixafor in healthy donors [1,2]. The effects of influenza A infection on stem cell mobilization are not known.
ISSN:1300-7777
1308-5263
DOI:10.4274/tjh.2017.0304